Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular matrix–like cell adhesion interfaces refer to the specialized structural and functional sites where cells interact with the extracellular matrix (ECM) or ECM-mimetic environments. These interfaces are primarily mediated by the integrin family of transmembrane receptors, which link the extracellular network of proteins—such as collagen, fibronectin, and laminin—to the intracellular actin cytoskeleton. Key structures within these interfaces include focal adhesions and hemidesmosomes, which serve as critical hubs for mechanotransduction and biochemical signaling. These interfaces play a vital role in regulating cell shape, migration, proliferation, and survival, making them central to physiological processes like wound healing and pathological conditions such as cancer metastasis and fibrosis. Therapeutic strategies targeting these interfaces typically involve small molecules or monoclonal antibodies that inhibit specific integrin-ligand interactions or modulate downstream signaling components like focal adhesion kinase (FAK).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular matrix–like cell adhesion interfaces.